Position in ROIV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$16,584,567
+$3,957,107 QoQ
Shares Held
468,623
+2.8% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#89
of 494 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. ROIV ranks #28 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
547,132 | $341,158,687 | |
| 2 | INCY |
Incyte Corp
|
1,587,996 | $180,015,226 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,829,545 | $159,078,937 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,179 | $143,643,884 | |
| 5 | EXEL |
Exelixis, Inc.
|
2,543,353 | $138,383,836 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
421,534 | $126,894,380 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
324,900 | $120,755,583 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
482,061 | $117,994,070 |
All Filings in ROIV
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,584,567 | 468,623 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $12,627,460 | 455,865 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,658,578 | 260,764 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $244,455 | 16,157 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $208,664 | 18,515 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $21,574,377 | 2,138,194 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,929,034 | 2,445,396 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $34,696,337 | 3,006,615 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $31,785,490 | 3,007,142 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $18,092,521 | 1,716,558 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $30,763,888 | 2,739,438 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,983,033 | 512,246 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,773,223 | 175,915 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,878,180 | 254,496 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||